ROCKWELL MEDICAL, INC. — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
On July 20, 2026, Rockwell Medical announced it regained compliance with Nasdaq Listing Rule 5550(a)(2) requiring a minimum closing bid price of $1.00 per share or greater. The company maintained this threshold from July 1–15, 2026, and Nasdaq closed the matter. The company remains listed on Nasdaq Capital Market under ticker RMTI with no delisting risk.
Why this rating
Delisting would have eliminated market access for a $28.7M company; regaining compliance removes existential trading risk and stabilizes market perception of viability.
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.